Keynote 1:

Jean Gelissen
Philips Research, Netherlands

Ambient Assisted Living for Active Healthy Aging

In the US seniors, making up 13% of the population, account for 36% of the total healthcare cost.  In the Euro zone the expenditure related to the ageing population is expected to grow from 0.9% of the GDP in 2010 (~ 9000B€) to 1.7% in 2050. This increase can be reduced by 40% to 60% if the mental and physical disability of elderly citizens stays in line with the increase of life expectancy (sources EU, WHO/Europe and Rock Health). It is the goal of the Action Line Health & Wellbeing (HWB) of the EIT ICT Labs to act on this economic and societal opportunity.

The HWB Action Line improves the quality of everyday life via the development of ICT enabled services supporting a sustainable healthy (mental, physical and social) lifestyle in the context of Ambient Assisted Living (AAL) for Active Healthy Ageing (AHA). Global and societal and economic trends as the ageing population and the growing consumer empowerment call for an innovative and entrepreneurial ICT enabled & supported approach towards Health and Wellbeing. This approach improves the quality of life by supporting people with ICT based solutions to live uncompromised, comfortable, safe, and active lives also at an advanced age and enables independent living while at the same time avoid social exclusion in other words, supporting active healthy ageing. This includes both regular as well as innovative emerging service providers.

Jean Gelissen studied at the Poly Technical School in Venlo, the Netherlands (graduated in Electronics, specialization Computer Technology, in 1977) and did a Post Graduate Course in Utrecht, The Netherlands (graduated in Informatics, 1986). His training was extended with a large number of technical and management courses from 1977 on during his professional career at Philips (Research Laboratories).

His professional career started in 1977 at Philips Research in Eindhoven, The Netherlands. He started in digital signal processing, both in software and hardware development, and gained large experience in computer networks, formal specification methods, multimedia as well as multimedia processing architectures and embedded software domain with a focus on architectures and methodology. He has been Department Head of the IPA (Information Processing Architectures) department (research group) in the Lifestyle program of Philips Research and has been appointed to Senior Director of Strategic Partnerships for the Lifestyle program that at Philips Research in 2006.

Keynote 2:

Prof Jacques Demongeot
University of Joseph Fourier, Grenoble, France


Serious game as new health telematics tool for patient therapy education: example of obesity and type 2 diabetes

Jhe recent introduction of the serious games technology in medical education allows dispatching the health knowledge in communities not actually still concerned by the e-learning. The medical cyber-universities are giving essentially primary knowledge to medical students and continuing education for MP’s, the paramedics being only a secondary target. The patient is rarely considered as a prior customer of the medical e-learning, but the increase of the chronic diseases as those emerging from the sequence overweight-obesity-diabetes of type 2 or from contamination spread facilitated by the new transportation modalities, with complex mode of propagation depending on their contagious (social or infectious) character, pushes to conceive active e-learning tools including a bio-feedback from the p`atient susceptible to increase its knowledge, level of responsibility, reactivity, compliance and observance with respect to the acute or long-term therapy and prevention policy concerning its disease. The paper presents the serious game as a user-friendly tool  susceptible to serve the objective of e-therapy education at home for patients suffering of long term chronic diseases.

Jacques Demongeot is presently director of the Laboratory TIMC (CNRS 5525) Techniques of Imaging, Modelling & Cognition and he is also head of the Institute of Bio-engineering (IFRT 130 IpV) at the University Joseph Fourier, Grenoble, France. He has MD and PhD in mathematics and has been appointed Chairman of Biomathematics at the Institut Universitaire de France in 1994. Jacques Demongeot is also responsible for the Department of Medical Information at the University Hospital of Grenoble (CHUG) and for the doctoral school of bio-engineering Health, Cognition & Environment.


Keynote 3:

Dr Takanori Shibata
National Institute of Advanced Industrial Science and Technology (AIST) & Tokyo Institute of Technology, Japan


Seal Robot, PARO, as a Neurological Therapeutic Medical Device

Robot therapy, which uses robots as a substitution for animals in “animal therapy,” is a new robot application in the fields of welfare and patient care. The seal robot PARO began development for robot therapy in 1993. PARO was commercialized in Japan in 2005 and in Europe and the U.S. in 2009. Since then, about 2,700 PAROs have been used in hospitals and care facilities in approximately 30 countries. Recent research has revealed that robot therapy has a similar effect on patients as animal therapy. In 2009, the U.S. Food and Drug Administration (FDA) certified PARO as a “bio-feedback medical device.” While PARO can be used in various kinds of therapy similar to real animals, this presentation focuses on its use with elderly dementia patients because explicit differences can be easily observed before and after interacting with PARO. First, the purposes and functions of PARO will be explained. Second, because there are several observational studies on the therapeutic effects of the elderly with dementia interacting with PARO, some typical cases and interesting special cases will be introduced. These cases include recovery from depression, reduction of agitation, and recovery from speech disorders. In addition, they include cases of reduction of usage of medications in dementia care. Finally, reasons why PARO has the potential to change moods and behaviors of the elderly with dementia as a non-pharmacological approach will be explained.

Dr. Takanori Shibata received Ph.D. in Electronic and Mechanical Engineering from Nagoya University in 1992. He was a research scientist at AIST from 1993 to 1998, and concurrently, at the Artificial Intelligence Lab., MIT from 1995 to 1998. Dr. Shibata has been a senior research scientist at AIST since 1998. He was the Deputy Director for ICT Policy, for the Government of Japan from 2009 to 2010. His research interests include human-robot interaction, robot therapy, and humanitarian de-mining. He is the inventor of a seal robot named PARO, the World’s Most Therapeutic Robot, according to the Guinness World Records in 2002.

Sample Image